If a patient doesnt respond very well to weight loss medications, continuing to take them may not make sense, Dr
Clinical Trials for Incretin-Based Therapy Highlighting the medications healthcare professionals can expect to see coming into the pipeline this year and next, Donna Ryan, MD, Professor Emeritus, Clinical Science, Pennington Biomedical Research Center at Louisiana State University, Baton Rouge, shared a robust overview of clinical trial data, including results from OASIS 1 and 4, STEP UP, and REDEFINE 1 and 2, reflecting the options and opportunities to better inform clinical decision-making
Here's how the two groups compared on reaching key weight loss milestones: Waist circumference also shrank more with tirzepatide: an average of 18.4 cm (about 7 inches) compared to 13.0 cm (about 5 inches) with semaglutide.[1] "The SURMOUNT-5 head-to-head results demonstrated tirzepatide led to greater weight reduction compared to semaglutide," said Dr
Recheck after 10-15 minutes and follow with a starchy snack if your next meal is not due